CEO Stole From His Company To Buy Mansion, SEC Says
The former CEO of a California-based pharmaceutical company agreed Wednesday to pay the U.S. Securities and Exchange Commission $30,000 to end a lawsuit accusing him of misappropriating $3.2 million in company... (more story)
Novo Nordisk Rejects Claim It Influences GLP-1 Market
Pharmaceutical giant Novo Nordisk told a Texas federal judge that it does not control the GLP-1 market and has not attempted to crush its competition in a bid to dismiss an antitrust suit it is facing.
Mass. AG, Insurer Settle Deceptive Marketing Claims For $5M
A Texas-headquartered health insurance agency will pay $5 million to settle allegations that it engaged in deceptive and unfair marketing to sell plans and other types of health programs to thousands of Massac... (more story)
5th Circ. Will Rehear Aetna Arbitration Bid In Aramark Suit
The full Fifth Circuit will reconsider insurance company Aetna's bid to force uniform and food services company Aramark to arbitrate its dispute over employee health benefit claims, staying a panel's ruling fr... (more story)
AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit
When the federal government included Botox in Medicare's drug price negotiation program, which allows Medicare officials to negotiate for lower drug prices, it overstepped its authority, drugmaker AbbVie Inc. ... (more story)
Medical Equipment Co. Settles Patient Overbilling Claims
Patients who claim Pennsylvania-based AdaptHealth Corp. overcharged them for returned medical equipment have reached the final version of a class settlement and will soon submit it to a North Carolina federal ... (more story)